# Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery

> **NCT07482540** · NA · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 140 (estimated)

## Conditions studied

- New Onset
- Atrial Fibrillation

## Interventions

- **DRUG:** Dexmedetomidine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT07482540
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07482540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07482540, "Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07482540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*